What Anavex Life Sciences Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Missling Christopher U | President and CEO | Sep 11 | Withheld — tax / exercise cost · F | −145,048 | $9.58 | −$1.39M | 1,510,165 |
| Missling Christopher U | President and CEO | Sep 11 | Exercise / conversion · M | +187,500 | $5.04 | +$945K | 1,655,213 |
| Thomas Steffen | Director | Jun 05 | Withheld — tax / exercise cost · F | −11,349 | $7.75 | −$88K | 43,651 |
| Thomas Steffen | Director | Jun 05 | Exercise / conversion · M | +50,000 | $1.76 | +$88K | 55,000 |
| Missling Christopher U | President and CEO | Mar 24 | Withheld — tax / exercise cost · F | −282,497 | $9.63 | −$2.72M | 1,467,713 |
| Missling Christopher U | President and CEO | Mar 24 | Exercise / conversion · M | +500,000 | $0.92 | +$460K | 1,750,210 |
| Donhauser Peter D.o. | Director | Jun 14 | Open-market buy · P | +2,835 | $3.64 | +$10.3K | 5,000 |
| Thomas Steffen | Director | May 15 | Open-market buy · P | +5,000 | $4.52 | +$22.6K | 5,000 |
| Missling Christopher U | President and CEO | Mar 28 | Open-market sale · S | −73,380 | $5.11 | −$375K | 1,250,210 |
| Missling Christopher U | President and CEO | Mar 28 | Exercise / conversion · M | +73,380 | $1.32 | +$96.9K | 1,323,590 |
| Missling Christopher U | President and CEO | Jun 29 | Exercise / conversion · M | +232,000 | $1.60 | +$371K | 1,250,210 |
| Missling Christopher U | President and CEO | Jun 28 | Open-market sale · S | −268,000 | $7.98 | −$2.14M | 1,018,210 |
| Missling Christopher U | President and CEO | Jun 28 | Exercise / conversion · M | +268,000 | $1.60 | +$429K | 1,286,210 |
| Skarpelos Athanasios | Director | May 25 | Open-market sale · S | −50,000 | $9.06 | −$453K | 1,306,458 |
| Skarpelos Athanasios | Director | May 25 | Exercise / conversion · M | +50,000 | $0.92 | +$46K | 1,356,458 |
| Boenisch Sandra | PFO and Treasurer | Jun 29 | Open-market sale · S | −166,696 | $26.53 | −$4.42M | 22,963 |
| Boenisch Sandra | PFO and Treasurer | Jun 29 | Exercise / conversion · M | +35,000 | $5.92 | +$207K | 189,659 |
| Boenisch Sandra | PFO and Treasurer | Jun 29 | Exercise / conversion · M | +106,696 | $3.28 | +$350K | 154,659 |
| Boenisch Sandra | PFO and Treasurer | Jun 29 | Exercise / conversion · M | +25,000 | $5.68 | +$142K | 47,963 |
| Missling Christopher U | President and CEO | Jun 29 | Open-market sale · S | −51,620 | $26.00 | −$1.34M | 1,018,210 |
Loading...
